Trial intelligence / Profile preview

Avonex plus Simvastatin in Clinically Isolated Syndrome

NCT00146068Phase 4Completed

Start
Sep 2004
Primary completion
Dec 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in clinically isolated syndrome (CIS) comparing Avonex + Zocor with Avonex + Placebo (2 arms). Primary endpoints: Relapse Rate at 1 year, Time to First Relapse at 1 year and 2 more. Started Sep 2004; status: completed.

02

Drugs

simvastatin
03

Conditions

clinically isolated syndrome (CIS)

Beyond the preview

Go deeper on NCT00146068.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00146068.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call